Blinatumomab: maka nnukwu ọrịa lymphoblastic leukemia
Ndinaya
Blinatumomab bụ ọgwụ injectable nke na-arụ ọrụ dị ka ihe mgbochi, na-agbakwunye na membranes nke mkpụrụ ndụ kansa na-ekwe ka usoro ahụ ji alụso ọrịa ọgụ mata nke ọma. Yabụ, sel ndị na - agbachitere nwere oge dị mfe iji wepu mkpụrụ ndụ cancer, ọkachasị na ọrịa lymphoblastic leukemia.
A pụkwara ịmara ọgwụ a dị ka Blincyto ma kwesiri iji ya n'ụlọ ọgwụ maka ọgwụgwọ kansa, n'okpuru nduzi nke oncologist.
Ahịa
A pụghị ịzụta ọgwụ a na ọgwụ ahịa ọgwụ, na-eji naanị n'oge ọgwụgwọ kansa n'ụlọ ọgwụ ma ọ bụ na ụlọ ọrụ pụrụ iche, dịka INCA, dịka ọmụmaatụ.
Gịnị ka ọ bụ maka
Blinatumomab egosiri maka ọgwụgwọ nnukwu ọrịa B-cell lymphoblastic leukemia buru ibu, Philadelphia chromosome na-adịghị mma, na nlọghachi ma ọ bụ na-ajụ.
Olee otú iji
Ọgwụ nke blinatumomab nke a ga-enye kwesịrị ka onye na-ahụ maka oncologist na-eduzi ya oge niile, n'ihi na ọ dịgasị iche dabere na njirimara onye ahụ na ọkwa nke mbido ọrịa ahụ.
A na-eme ọgwụgwọ ahụ site na usoro 2 nke izu 4 ọ bụla, nkewapụtara site na izu abụọ, na ị ga-abanye n'ụlọ ọgwụ n'oge ụbọchị 9 mbụ nke usoro izizi na ụbọchị 2 nke usoro nke abụọ.
Omume puru omume
Mmetụta kachasị emetụta n'iji ọgwụgwọ a gụnyere ọrịa anaemia, ike ọgwụgwụ gabigara ókè, ọbara mgbali elu, ehighị ụra nke ọma, isi ọwụwa, ịma jijiji, dizziness, ụkwara, ọgbụgbọ, ọgbụgbọ, afọ ntachi, afọ mgbu, azụ mgbu, ahụ ọkụ, mgbu na nkwonkwo, oyi na mgbanwe n'ọbara ọbara.
Onye na-ekwesịghị iji
A na-egbochi Blinatumomab maka ndị inyom na-enye nwa ara na ndị mmadụ na-arịa ihe gbasara ihe ọ bụla n'ime usoro ahụ. Na mgbakwunye, n'ihe banyere ụmụ nwanyị dị ime, ekwesịrị iji ya naanị n'okpuru nduzi nke obstetrician.